Stay updated with breaking news from Nathan Dowden. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BOSTON, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA), a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing intracellular Endosomal Escape Vehicle (EEV™)-therapeutics
Posted on 290 Entrada Therapeutics, a privately-held biotechnology company dedicated to transforming the treatment of devastating diseases using intracellular biologics, today announced the appointment of Peter S. Kim, Ph.D., to its Board of Directors. “Dr. Kim is a pioneering scientist with over 30 years of experience in both academia and the biopharmaceutical industry,” stated Dipal Doshi, President and CEO of Entrada Therapeutics. “He has been recognized with countless honors, awards and appointments throughout the course ...